Vistagen Therapeutics, Inc. (VTGN)
0.7727
+0.03
(+4.42%)
USD |
NASDAQ |
Dec 19, 16:00
0.7606
-0.01
(-1.57%)
After-Hours: 20:00
Vistagen Therapeutics Shareholders Equity (Annual): 70.39M for March 31, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Vanda Pharmaceuticals, Inc. | 538.55M |
| XOMA Royalty Corp. | 81.92M |
| Omeros Corp. | -182.61M |
| GeoVax Labs, Inc. | 5.048M |
| Daré Bioscience, Inc. | -6.012M |